検索結果 - David A. Scheinberg

結果の絞り込み
  1. 1
    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

    Actinium-225 in Targeted Alpha-Particle Therapeutic Applications 著者: David A. Scheinberg, Michael R. McDevitt

    出版事項 2011
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications

    Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications 著者: Matthias Miederer, David A. Scheinberg, Michael R. McDevitt

    出版事項 2008
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer

    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with <sup>225</sup>Ac for α-Particle Radioimmunotherapy of Cancer 著者: William F. Maguire, Michael R. McDevitt, Peter Smith‐Jones, David A. Scheinberg

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Chimeric and humanized antibodies with specificity for the CD33 antigen.

    Chimeric and humanized antibodies with specificity for the CD33 antigen. 著者: M S Co, N M Avdalovic, Philip Caron, Mark Avdalovic, David A. Scheinberg, Cary Queen

    出版事項 1992
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase

    Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase 著者: De-Ming Chau, Christina J. Crump, Jennifer C. Villa, David A. Scheinberg, Yue‐Ming Li

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Carbon nanotubes as vaccine scaffolds

    Carbon nanotubes as vaccine scaffolds 著者: David A. Scheinberg, Michael R. McDevitt, Tao Dao, J. Justin Mulvey, Evan N. Feinberg, Simone Alidori

    出版事項 2013
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  7. 7
    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers

    Enhanced Retention of the α-Particle-Emitting Daughters of Actinium-225 by Liposome Carriers 著者: Stavroula Sofou, Barry J. Kappel, Jaspreet Singh Jaggi, Michael R. McDevitt, David A. Scheinberg, George Sgouros

    出版事項 2007
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

    Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia 著者: Joseph G. Jurcic, Stephen D. Nimer, David A. Scheinberg, Tony DeBlasio, Raymond P. Warrell, Wilson H. Miller

    出版事項 2001
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters

    Renal Tubulointerstitial Changes after Internal Irradiation with α-Particle–Emitting Actinium Daughters 著者: Jaspreet Singh Jaggi, Surya V. Seshan, Michael R. McDevitt, Krista LaPerle, George Sgouros, David A. Scheinberg

    出版事項 2005
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia 著者: Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

    Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics 著者: Niloufar Ataie, Jingyi Xiang, Neal Cheng, Elliott J. Brea, Wenjie Lu, David A. Scheinberg, Liu C, Ho Leung Ng

    出版事項 2015
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

    Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs 著者: Mark Heaney, Jeffrey R. Gardner, Nicos Karasavvas, David W. Golde, David A. Scheinberg, Emily A. Smith, Owen A. O’Connor

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells 著者: Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen

    Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen 著者: Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan, Mythili Koneru, Tao Dao, C Liu, David A. Scheinberg, Renier J. Brentjens

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Rejection of immunogenic tumor clones is limited by clonal fraction

    Rejection of immunogenic tumor clones is limited by clonal fraction 著者: Ron S. Gejman, Aaron Y. Chang, Heather F. Jones, Krysta M. DiKun, A. Ari Hakimi, Andrea Schietinger, David A. Scheinberg

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias

    A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias 著者: Leonid Dubrovsky, Dmitry Pankov, Elliott J. Brea, Tao Dao, Andrew Scott, Su Yan, Richard J. O’Reilly, Liu C, David A. Scheinberg

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Opportunities and challenges for TCR mimic antibodies in cancer therapy

    Opportunities and challenges for TCR mimic antibodies in cancer therapy 著者: Aaron Y. Chang, Ron S. Gejman, Elliott J. Brea, Claire Y. Oh, Melissa Mathias, Dmitry Pankov, Emily Casey, Tao Dao, David A. Scheinberg

    出版事項 2016
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  18. 18
    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors

    Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors 著者: Freddy E. Escorcia, Erik Henke, Michael R. McDevitt, Carlos H. Villa, Peter Smith‐Jones, Ronald G. Blasberg, Robert Benezra, David A. Scheinberg

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody

    Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody 著者: Jazmin Schwartz, Jaspreet Singh Jaggi, Joseph A. O’Donoghue, Shanming Ruan, Michael R. McDevitt, Steven M. Larson, David A. Scheinberg, John L. Humm

    出版事項 2011
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

    A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia 著者: Prabodhika Mallikaratchy, Alessandro Ruggiero, Jeffrey R. Gardner, Vitaly Kuryavyi, William F. Maguire, Mark Heaney, Michael R. McDevitt, Dinshaw J. Patel, David A. Scheinberg

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: